nach oben

Erschienen in:

09.06.2021 | Special Section: HCC Treatment

LI-RADS treatment response lexicon: review, refresh and resolve with emerging data

verfasst von: Roopa Ram, Rony Kampalath, Anuradha S. Shenoy-Bhangle, Sandeep Arora, Ania Z. Kielar, Mishal Mendiratta-Lala

Erschienen in: Abdominal Radiology | Ausgabe 8/2021

Einloggen, um Zugang zu erhalten

Abstract

The imaging findings after loco regional treatment of hepatocellular carcinoma are variable based on the type of treatment used, the timing interval of imaging after treatment, and the cross-sectional modality used for treatment response assessment. Liver Imaging Reporting and Data System (LI-RADS) Treatment Response Algorithm (TRA) is a relatively new standardized method of evaluating treatment response after loco regional therapy to hepatocellular carcinoma. In this article, we provide an overview of the evolution of the treatment response algorithm, its current applicability and its outlook for the future. We will review current guidelines and discuss proposed changes to the algorithm as a means to continually improve LI-RADS TRA as an assessment tool post-loco regional treatment of hepatocellular carcinoma.

Kis B, El-Haddad G, Sheth RA, Parikh NS, Ganguli S, Shyn PB, Choi J, Brown KT (2017) Liver-Directed Therapies for Hepatocellular Carcinoma and Intrahepatic Cholangiocarcinoma. Cancer Control 24(3):1073274817729244. https://doi.org/10.1177/1073274817729244CrossRefPubMedPubMedCentral

Kim DG, Lee JG, Joo DJ, Kim SI, Kim MS (2019) Favourable outcome of pathologic down staging by loco regional treatment for hepatocellular carcinoma in liver transplantation. Sci Rep 9(1):10386-019-46871–9. https://doi.org/10.1038/s41598-019-46871-9CrossRefPubMedPubMedCentral

Elsayes KM, Kielar AZ, Chernyak V, Morshid A, Furlan A, Masch WR, Marks RM, Kamaya A, Do RKG, Kono Y, Fowler KJ, Tang A, Bashir MR, Hecht EM, Jambhekar K, Lyshchik A, Rodgers SK, Heiken JP, Kohli M, Fetzer DT, Wilson SR, Kassam Z, Mendiratta-Lala M, Singal AG, Lim CS, Cruite I, Lee J, Ash R, Mitchell DG, McInnes MDF, Sirlin CB (2019) LI-RADS: a conceptual and historical review from its beginning to its recent integration into AASLD clinical practice guidance. J Hepatocell Carcinoma 6:49–69. https://doi.org/10.2147/JHC.S186239CrossRefPubMedPubMedCentral

Tang A, Singal AG, Mitchell DG, Hecht EM, Fowler KJ, Kulik L, Parikh ND, Kono Y, Sirlin CB (2019) Introduction to the Liver Imaging Reporting and Data System for Hepatocellular Carcinoma. Clin Gastroenterol Hepatol 17(7):1228–1238.CrossRef

Do RK, Chernyak V, Foltz G, Fowler KJ, Kambadakone A, Kielar AZ, Kim CY, Kono Y, Lewis S, Maturen K, Meyer J, Miller FH, Mitchell DG, Newton IG, Piscaglia F, Raman SS, Saad NES, Salem R, Sirlin CB, Tang A, Yaghmai V, Yarmohammadi H, Yokoo T (2018) LI-RADS Treatment Response. In: Chernyak V, Sirlin CB (eds) (2018) The LI-RADS® v2018 Manual. American College of Radiology Committee on LI-RADS®. American College of Radiology, Virginia, pp 9.1–9.53 https://www.acr.org/-/media/ACR/Files/Clinical-Resources/LIRADS/Chapter-9-Treatment-response.pdf?la=en

Chernyak V, Sirlin CB (eds) (2018) The LI-RADS® v2018 Manual. American College of Radiology Committee on LI-RADS®. American College of Radiology, Virginia. https://www.acr.org/-/media/ACR/Files/Clinical-Resources/LIRADS/LI-RADS-2018-Manual-5Dec18.pdf

Mendiratta-Lala M, Masch W, Owen D, Aslam A, Maurino C, Devasia T, Schipper MJ, Parikh ND, Cuneo K, Lawrence TS, Davenport MS (2020a) Natural history of hepatocellular carcinoma after stereotactic body radiation therapy. Abdom Radiol (NY) 45(11):3698–3708. https://doi.org/10.1007/s00261-020-02532-4CrossRef

Voizard N, Cerny M, Assad A, Billiard JS, Olivié D, Perreault P, Kielar A, Do RKG, Yokoo T, Sirlin CB, Tang A (2019) Assessment of hepatocellular carcinoma treatment response with LI-RADS: a pictorial review. Insights into Imaging 10(1):121-019-0801-z. https://doi.org/10.1186/s13244-019-0801-zCrossRefPubMedPubMedCentral

Aslam A, Do RKG, Kambadakone A, Spieler B, Miller FH, Gabr AM, Charalel RA, Kim CY, Madoff DC, Mendiratta-Lala M (2020) Hepatocellular carcinoma Liver Imaging Reporting and Data Systems treatment response assessment: Lessons learned and future directions. World J Hepatol 12(10):738–753. https://doi.org/10.4254/wjh.v12.i10.738CrossRefPubMedPubMedCentral

10.

Kim KW, Lee JM, Choi BI (2011) Assessment of the treatment response of HCC. Abdom Imaging 36(3):300–314. https://doi.org/10.1007/s00261-011-9683-3CrossRefPubMed

11.

Miszczuk MA, Chapiro J, Geschwind JH, Thakur V, Nezami N, Laage-Gaupp F, Kulon M, van Breugel JMM, Fereydooni A, Lin M, Savic LJ, Tegel B, Wahlin T, Funai E, Schlachter T (2020) Lipiodol as an Imaging Biomarker of Tumor Response After Conventional Transarterial Chemoembolization: Prospective Clinical Validation in Patients with Primary and Secondary Liver Cancer. Transl Oncol 13(3):100742.CrossRef

12.

Gregory J, Dioguardi Burgio M, Corrias G, Vilgrain V, Ronot M (2020) Evaluation of liver tumour response by imaging. JHEP Rep 2(3):100100. https://doi.org/10.1016/j.jhepr.2020.100100CrossRefPubMedPubMedCentral

13.

Chapiro J, Duran R, Lin M, Schernthaner R, Lesage D, Wang Z, Savic LJ, Geschwind JF (2015) Early survival prediction after intra-arterial therapies: a 3D quantitative MRI assessment of tumour response after TACE or radioembolization of colorectal cancer metastases to the liver. Eur Radiol 25(7):1993–2003. https://doi.org/10.1007/s00330-015-3595-5CrossRefPubMedPubMedCentral

14.

Hass P, Mohnike K (2014) Extending the Frontiers Beyond Thermal Ablation by Radiofrequency Ablation: SBRT, Brachytherapy, SIRT (Radioembolization). Viszeralmedizin 30(4):245–252. https://doi.org/10.1159/000366088CrossRefPubMedPubMedCentral

15.

Kellock T, Liang T, Harris A, Schellenberg D, Ma R, Ho S, Yap WW (2018) Stereotactic body radiation therapy (SBRT) for hepatocellular carcinoma: imaging evaluation post treatment. J Radiol 91(1085):20170118. https://doi.org/10.1259/bjr.20170118CrossRef

16.

Gervais DA, Arellano RS (2011) Percutaneous tumor ablation for hepatocellular carcinoma. AJR Am J Roentgenol 197(4):789–794. https://doi.org/10.2214/AJR.11.7656CrossRefPubMed

17.

Do RK, Mendiratta-Lala M (2020) LI-RADS Version 2018 Treatment Response Algorithm: The Evidence Is Accumulating. Radiology 294(2):327–328. https://doi.org/10.1148/radiol.2020192484CrossRefPubMed

18.

Chaudhry M, McGinty KA, Mervak B, Lerebours R, Li C, Shropshire E, Ronald J, Commander L, Hertel J, Luo S, Bashir MR, Burke LMB (2020) The LI-RADS Version 2018 MRI Treatment Response Algorithm: Evaluation of Ablated Hepatocellular Carcinoma. Radiology 294(2):320–326. https://doi.org/10.1148/radiol.2019191581CrossRefPubMed

19.

Rudnick SR, Russo MW (2018) Liver transplantation beyond or down staging within the Milan criteria for hepatocellular carcinoma. Expert Rev Gastroenterol Hepatol 12(3):265–275. https://doi.org/10.1080/17474124.2018.1417035CrossRefPubMed

20.

Shropshire EL, Chaudhry M, Miller CM, Allen BC, Bozdogan E, Cardona DM, King LY, Janas GL, Do RK, Kim CY, Ronald J, Bashir MR (2019) LI-RADS Treatment Response Algorithm: Performance and Diagnostic Accuracy. Radiology 292(1):226–234. https://doi.org/10.1148/radiol.2019182135CrossRefPubMed

21.

Seo N, Kim MS, Park MS, Choi JY, Do RKG, Han K, Kim MJ (2020) Evaluation of treatment response in hepatocellular carcinoma in the explanted liver with Liver Imaging Reporting and Data System version 2017. Eur Radiol 30(1):261–271. https://doi.org/10.1007/s00330-019-06376-5CrossRefPubMed

22.

Park S, Joo I, Lee DH, Bae JS, Yoo J, Kim SW, Lee JM (2020) Diagnostic Performance of LI-RADS Treatment Response Algorithm for Hepatocellular Carcinoma: Adding Ancillary Features to MRI Compared with Enhancement Patterns at CT and MRI. Radiology 296(3):554–561. https://doi.org/10.1148/radiol.2020192797CrossRefPubMed

23.

Kim SW, Joo I, Kim HC, Ahn SJ, Kang HJ, Jeon SK, Lee JM (2020) LI-RADS treatment response categorization on gadoxetic acid-enhanced MRI: diagnostic performance compared to mRECIST and added value of ancillary features. Eur Radiol 30(5):2861–2870. https://doi.org/10.1007/s00330-019-06623-9CrossRefPubMed

24.

Saleh TY, Bahig S, Shebrya N, Ahmed AY (2019) Value of dynamic and DWI MRI in evaluation of HCC viability after TACE via LI-RADS v2018 diagnostic algorithm. Egyptian Journal of Radiology and Nuclear Medicine 50(1):113. https://doi.org/10.1186/s43055-019-0120-xCrossRef

25.

Thibodeau-Antonacci A, Petitclerc L, Gilbert G, Bilodeau L, Olivié D, Cerny M, Castel H, Turcotte S, Huet C, Perreault P, Soulez G, Chagnon M, Kadoury S, Tang A (2019) Dynamic contrast-enhanced MRI to assess hepatocellular carcinoma response to Transarterial chemoembolization using LI-RADS criteria: A pilot study. Magnetic resonance imaging 62:78–86.CrossRef

Titel: LI-RADS treatment response lexicon: review, refresh and resolve with emerging data
verfasst von: Roopa Ram
Rony Kampalath
Anuradha S. Shenoy-Bhangle
Sandeep Arora
Ania Z. Kielar
Mishal Mendiratta-Lala
Publikationsdatum: 09.06.2021
Verlag: Springer US
Erschienen in: Abdominal Radiology / Ausgabe 8/2021
Print ISSN: 2366-004X
Elektronische ISSN: 2366-0058
DOI: https://doi.org/10.1007/s00261-021-03149-x

Update Radiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Live-Webinar "Urologie und Sexualmedizin in der Praxis"

Springer Medizin

LI-RADS treatment response lexicon: review, refresh and resolve with emerging data

Abstract

Neu im Fachgebiet Radiologie

Mammakarzinom: Brustdichte beeinflusst rezidivfreies Überleben

„Übersichtlicher Wegweiser“: Lauterbachs umstrittener Klinik-Atlas ist online

Klinikreform soll zehntausende Menschenleben retten

Darf man die Behandlung eines Neonazis ablehnen?

Update Radiologie

Live-Webinar "Urologie und Sexualmedizin in der Praxis"

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 8/2021

Therapies for hepatocellular carcinoma: overview, clinical indications, and comparative outcome evaluation—part one: curative intention

Therapies for hepatocellular carcinoma: overview, clinical indications, and comparative outcome evaluation. Part two: noncurative intention

The new pathways of spread of anal fistula and the pivotal role of MRI in discovering them

Change in hepatic volume profile in potential live liver donors after lifestyle modification for reduction of hepatic steatosis

Artificial intelligence in assessment of hepatocellular carcinoma treatment response

Cryptogenic multifocal ulcerous stenosing enteritis (CMUSE): a 20-year single-center clinical and radiologic experience

Neu im Fachgebiet Radiologie

Mammakarzinom: Brustdichte beeinflusst rezidivfreies Überleben

„Übersichtlicher Wegweiser“: Lauterbachs umstrittener Klinik-Atlas ist online

Klinikreform soll zehntausende Menschenleben retten

Darf man die Behandlung eines Neonazis ablehnen?

Update Radiologie